subscribeSubscribe
With $640M in sales of Lagevrio, Merck bumps up revenue forecast

With $640M in sales of Lagevrio, Merck bumps up revenue forecast
Kevin Dunleavy FIERCE PHARMA
26 Oct 2023
Share Share
Merck`s Lagevrio to be sold commercially in November, HHS says

Merck`s Lagevrio to be sold commercially in November, HHS says
Zoey Becker FIERCE PHARMA
05 Oct 2023
Share Share
Merck`s Lagevrio may have triggered new COVID variants: study

Merck`s Lagevrio may have triggered new COVID variants: study
Kevin Dunleavy FIERCE PHARMA
26 Sep 2023
Share Share
Pfizer, Merck trim prices in China for Paxlovid, molnupiravir

Pfizer, Merck trim prices in China for Paxlovid, molnupiravir
REUTERS
04 Apr 2023
Share Share
Merck asks EMA to reevaluate rejected Covid-19 antiviral

Merck asks EMA to reevaluate rejected Covid-19 antiviral
ENDPTS
14 Mar 2023
Share Share
EU regulator recommends against approval for Merck`s COVID pill for adults

EU regulator recommends against approval for Merck`s COVID pill for adults
REUTERS
25 Feb 2023
Share Share
Merck and Ridgeback Provide Update on EU MAA for LAGEVRIO

Merck and Ridgeback Provide Update on EU MAA for LAGEVRIO
BUSINESSWIRE
24 Feb 2023
Share Share
Merck falls short in PhIII Covid-19 prophylaxis trial, joining Pfizer

Merck falls short in PhIII Covid-19 prophylaxis trial, joining Pfizer
Paul Schloesser ENDPTS
22 Feb 2023
Share Share
Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating LAGEVRIO

Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating LAGEVRIO
BUSINESSWIRE
21 Feb 2023
Share Share
China Approves Merck’s Covid Pill Amid Shortage of Drugs

China Approves Merck’s Covid Pill Amid Shortage of Drugs
Ahmed Aboulenein CAIXINGLOBAL
31 Dec 2022
Share Share